• Markets
  • icon
  • Companies
RMD · ASX

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX:RMD)

AU$30.41

 0.51 (1.706%)
ASX:Live
15/07/2024 03:30:41 PM
Hammer Bearish HALO Ords HALO Capital Efficiency HALO 50 HALO 200 +5
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

RMD Overview

RMD Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Neutral

GARP

Neutral

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

About RMD

Telephone

Address

Description

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

RMD Price Chart

Key Stats

Market Cap

AU$41.66B

PE

34.10

EV/EBITDA

24.9

Dividends Overview

DIV Yield

.8%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 21.14 - 34.27

Trade Value (12mth)

US$12,432,571.00

1 week

4.4%

1 month

-6.36%

YTD

17.76%

1 year

-6.5%

All time high

40.79

Key Fundamentals

EPS 3 yr Growth

42.000%

EBITDA Margin

31.90%

Operating Cashflow

$693m

Free Cash Flow Return

14.00%

ROIC

18.10%

Interest Coverage

22.20

Quick Ratio

1.80

Other Data

Shares on Issue (Fully Dilluted)

1474m

HALO Sector

Next Company Report Date

02-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.66

RMD Announcements

Latest Announcements

Date Announcements

04 July 24

ResMed to Report Fourth Quarter Fiscal 2024 Results

×

ResMed to Report Fourth Quarter Fiscal 2024 Results

02 July 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

04 June 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

31 May 24

FORM SD

×

FORM SD

27 May 24

Share Registry Change of Address

×

Share Registry Change of Address

10 May 24

Update - Dividend/Distribution - RMD

×

Update - Dividend/Distribution - RMD

03 May 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

29 April 24

Form 10-Q for the Quarter ended March 31, 2024

×

Form 10-Q for the Quarter ended March 31, 2024

26 April 24

ResMed Announces Results for the Third Quarter of FY2024

×

ResMed Announces Results for the Third Quarter of FY2024

26 April 24

Dividend/Distribution - RMD

×

Dividend/Distribution - RMD

05 April 24

ResMed to Report Third Quarter Fiscal 2024 Results

×

ResMed to Report Third Quarter Fiscal 2024 Results

04 April 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

04 March 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

09 February 24

Update - Dividend/Distribution - RMD

×

Update - Dividend/Distribution - RMD

05 February 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

29 January 24

Form 10-Q for the Quarter ended December 31, 2023

×

Form 10-Q for the Quarter ended December 31, 2023

25 January 24

ResMed Announces Results for the Second Quarter of FY2024

×

ResMed Announces Results for the Second Quarter of FY2024

25 January 24

Dividend/Distribution - RMD

×

Dividend/Distribution - RMD

05 January 24

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

04 January 24

ResMed to Report Second Quarter Fiscal 2024 Results

×

ResMed to Report Second Quarter Fiscal 2024 Results

05 December 23

Statement of CDIs on issue - RMD

×

Statement of CDIs on issue - RMD

21 November 23

ResMed Inc. Amended and Restated Bylaws

×

ResMed Inc. Amended and Restated Bylaws

21 November 23

Form 8K

×

Form 8K

10 November 23

ResMed Adopts New Operating Model

×

ResMed Adopts New Operating Model

10 November 23

Update - Dividend/Distribution - RMD

×

Update - Dividend/Distribution - RMD

RMD Fundamentals

Per Share Records

Historical data

Forecasted data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.33 0.53 0.61 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.32 0.53 0.61 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.2 63.4 14.6 Lock Lock Lock
     PE X Lock Lock Lock Lock 53.2 43.1 34.1 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 38.3 30.4 24.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.50 0.72 0.79 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.28 -0.02 0.21 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.7 43.3 8.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.1 -0.1 1.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.11 0.12 0.15 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.6 9.9 22.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.6 0.7 0.8 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 34 23 24 Lock Lock Lock
BPS $ Lock Lock Lock Lock 1.98 2.30 2.81 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.39 0.74 0.55 Lock Lock Lock
     Growth % Lock Lock Lock Lock 254.6 89.8 -25.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,465 1,470 1,475 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,453 1,461 1,468 Lock Lock Lock

Financial Records

Historical data

Forecasted data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 3,197 3,578 4,223 Lock Lock Lock
     Growth % Lock Lock Lock Lock 8.1 11.9 18.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 896 993 1,162 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1,808 1,993 2,314 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.1 10.2 16.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 56.6 55.7 54.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 43 44 45 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 1,104 1,194 1,349 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.5 8.2 12.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 34.5 33.4 31.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 192 194 197 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 912 1,000 1,152 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.8 9.6 15.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 28.5 28.0 27.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 884 960 1,102 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 409 181 204 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 475 779 898 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.7 64.3 15.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 14.8 21.8 21.3 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 737 351 693 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 117 156 134 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -158 -230 -1,160 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -765 -128 423 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 634 216 574 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.3 -65.9 165.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 295 274 228 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 4,728 5,096 6,752 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 758 886 1,548 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 498 644 1,352 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1,842 1,735 2,622 Lock Lock Lock
Equity $m Lock Lock Lock Lock 2,867 3,544 4,173 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3,644 4,247 5,678 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.2 16.5 33.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 10.0 15.3 13.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 16.5 22.0 21.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 23.5 24.8 23.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 12.3 19.5 18.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 19.1 8.8 14.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 46.0 53.5 22.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.5 1.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 17.4 18.2 32.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.7 2.8 3.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.2 1.7 1.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 18.8 14.2 9.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 80.8 50.9 91.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.6 5.8 6.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 3.1 2.6 2.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 4.9 2.7 2.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.3 4.7 3.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.7 0.7 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.7 0.7 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 27.6 26.8 26.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 18.7 18.8 16.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 46.3 18.8 18.5 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 10.0 15.3 13.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.6 1.4 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 16.5 22.0 21.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 66.3 77.4 75.8 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 11.0 17.0 16.3 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 119.0 141.2 165.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 65.4 63.2 57.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 184.4 204.3 223.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 37.3 28.5 25.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 147.1 175.8 197.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

22.60%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.66%

Value ($M)

121

Prior Change

N/A

7 Day Change

0.10%

1 Month Change

0.40%

3 Month Change

-0.40%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

RMD Shortsell

Frequently Asked Questions

The current share price of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is AU$30.41.
The 52-week high share price for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is AU$34.27.
The 52-week low share price for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX)? is AU$21.14.
The current TTM dividend payout for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is 0.80.
The last dividend payment of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is AU$0.07.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) has a franking level of 0.0%.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is classified in the Healthcare.
The current P/E ratio for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD:ASX) is 34.10.